Scholarly Index
Huifeng Yun
GlaxoSmithKline (United States); 5,107 total citations; 159 total publications; best world rank #373
GlaxoSmithKline (United States)
5,107Total citations
159Total publications
40H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Rheumatoid Arthritis Research and Therapies | Lifetime | 740 | US 189 | 97.23 |
| Biosimilars and Bioanalytical Methods | Lifetime | 373 | US 136 | 94.37 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 848 | US 123 | 88.79 |
| Bartonella species infections research | 2021-2025 | 425 | US 84 | 15.39 |